IBLHL news and notes IBL HealthCare Limited
IBL HealthCare Limited (IBLHL) news and notes: the SuperX note and what changed (4 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.
What SuperX wrote about IBLHL
IBLHL fell 0.72% to PKR 41.58 on 20 Nov. The pharmaceuticals sector median was flat, and 8 of 15 scrips fell.
The half-year period ends 31 Dec. Last year the company filed its half-year results on 24 Feb.
Net profit for the quarter ended 30 Sep fell 8.09% to PKR 64.05M. Sales were flat at PKR 1121.18M.
Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 20 Nov 2026. Each number was checked against those figures. Not advice.
What changed for IBLHL, newest first
- 20 Nov 2026Closed 41.58, -0.72%. Volume 112,167, 1.1 times the average of the 30 sessions before it, 104,223.
- 19 Nov 2026Trend read changed to sideways: above the 50-day average, below the 200-day; down 12.8% over 3 months; fell 53.5% from its 1-year peak at worst.
- 29 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 0.65, sales Rs 1.1 bn, down 8.5% on the same quarter a year before.
- NextHalf-year results (to 31 Dec 2026) expected 19 Feb 2027 – 1 Mar 2027, a projection. An estimate from the dates of the last 8 filings.
As of the close of 20 Nov 2026. Closes and notices: PSX. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.
More on IBLHL
- IBLHL share price and overview
- IBLHL dividend history
- Pharmaceuticals sector
- MACTER news and notes · Macter International Limited
- HALEON news and notes · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .